- Global Pharma News & Resources

Mesenchymal Stem Cells Market Potential Growth, Current Scenario, Size, Share, Prominent Players, Demand and Trends| CMI Unleashes the Forecast to 2026

Mesenchymal stem cells, also known as Mesenchymal Stromal Cells (MSCs), are multipotent stromal cells that can differentiate into various cells such as adipocytes, osteoblasts, and chondroblasts. These cells are isolated from the bone marrow initially, and then from various sources such as adipose tissue, molar cells, and cord cells. MSCs are smaller in size and are quite hard to observe in histological sections. A group of MSCs are called mesenchyme and is distributed in the body. These cells can multiply in number of specialized cells and can grow in in-vivo and in-vitro condition.

*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.

Request PDF Research Report Brochure @

The MSCs play a key role within an organism for suppression of immune cells activation, increase the number of newer cells, reduce cell death or cell damage in the body, and secretion of both neurotrophic and angiogenic factors. These factors are responsible for stabilization of extracellular matrix. When they are transplanted into the brain, these cells support the decrease of free radical levels and augment synaptic connections of damaged neurons, and also increase the myelination of axons. The mesenchymal cells can also replace and repair any damaged blood vessel in the cerebrum brain.

Global Mesenchymal Stem Cells Market Taxonomy

On the basis of product type, the global mesenchymal Stem Cells Market is segmented into:

  • Human MSCs
  • Mouse MSCs
  • Rat MSCs
  • Others

On the basis of application, the global mesenchymal Stem Cells Market is segmented into:

  • Drug discovery and development
  • Injuries
  • Cardiovascular and myocardial infarction
  • Others

On the basis of geography, the global mesenchymal Stem Cells Market is segmented into:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @

Increase in prevalence of osteoporosis and cancer incidences are expected to drive the global market growth

MSCs can grow new bone tissues through the bone surface, which have the ability to treat osteoporosis. According to the National Institute of Health (NIH), in 2015, around 53 million people were suffering from osteoporosis or at a high risk due to low bone mass in the U.S.

Moreover, according to Osteoporosis Canada, around 1 in 5 men and 1 in 3 women suffer from osteoporotic fracture during their lifetime, while osteoporosis causes around 70-90% of 30,000 hip fractures annually in Canada. According to the same source, the annual cost to Canada for treating osteoporosis was around US$ 4.0 billion in 2012, which is expected to increase in the near future. Furthermore, according to the International Osteoporosis Foundation (IOF), around 9 million people across the globe suffer from osteoporosis fractures annually. Therefore, these factors are expected to drive the global mesenchymal stem cells market growth during the forecast period.

North America and Asia Pacific are expected to hold significant market share followed by Europe. This is owing to rapid growth in technological innovations, the well-equipped healthcare centers, and high disposable incomes, which will eventually drive growth of global mesenchymal stem cells market over the forecast period. Furthermore, implantation of new mesenchymal stem cells in cancer patients is expected to enhance growth the market in the near future.

According to the World Health Organization (WHO), in 2012, around 14 million cases of cancer were registered globally and around 8.8 million deaths were accounted in 2015; According to the same source, in 2012, Europe witnessed over 3.7 million cases of cancer and around 8.3 million deaths in. Furthermore, according to National Center for Biotechnology Information (NCBI), in 2012, in Asia Pacific, breast cancer in females was found to be around 18.0% and it was the fourth most cause for around 9% death due to cancer in the region.

Special Requirements?
We value your investment and offer customization as per your requirements.

Share your precise requirements @

Global Mesenchymal Stem Cells Market Players

Major market players involved in the global mesenchymal stem cells market are, Pluristem Therapeutics, LonzaThermo, Fisher, ATCC, Bio-Techne, MilliporeSigma, Genlantis, Celprogen, Cell Applications, PromoCell GmbH, Cyagen Biosciences, Human Longevity Inc., Axol Bioscience, Cytori Therapeutics, Eutilex Co.Ltd., ID Pharma Co. Ltd., BrainStrom Cell Therapeutics, Cytori Therapeutics Inc., Neovii Biotech, Angel Biotechnology, California Stem Cell Inc., Stemcelltechnologies Inc., and Celgene Corporation Inc.

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 21-Jul-2020